LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Chiome Bioscience Inc.
Headquarters:
Tokyo, Japan
Website:
http://www.chiome.co.jp
Year Founded:
2005
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Shigeru Kobayashi
Number Of Employees:
N/A
Enterprise Value:
$88,866,007
PE Ratio:
-8.67
Exchange/Ticker 1:
Tokyo:4583
Exchange/Ticker 2:
N/A
Latest Market Cap:
$69,274,613
BioCentury
|
Sep 15, 2020
Product Development
Data Bytes: Trodelvy leads TROP2 pack
Read More
BioCentury
|
Jul 13, 2017
Company News
ADC Therapuetics options one Chiome antibody, declines another
Read More
BioCentury
|
Apr 11, 2016
Company News
Chiome, ADC Therapeutics deal
Read More
BioCentury
|
Aug 3, 2015
Company News
Chiome, ADC Therapeutics deal
Read More
BioCentury
|
Apr 6, 2015
Finance
Up, up and acquired
Winners, losers in biotech stock tiers in 1Q15
Read More
BioCentury
|
Feb 23, 2015
Finance
Daiwa dives in
How Daiwa plans to invest first biotech fund in Japan, Taiwan
Read More
BioCentury
|
Mar 24, 2014
Company News
Chiome antibodies news
Read More
BioCentury
|
Mar 24, 2014
Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
Read More
BioCentury
|
Feb 10, 2014
Finance
A Japanese correction
Japanese biotechs see large correction but still up since January 2013
Read More
BioCentury
|
Jul 1, 2013
Company News
Chiome antibodies news
Read More
Items per page:
10
1 - 10 of 35